Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 74 (GAPDHP74) is a processed pseudogene, meaning it originated from retrotransposition of mRNA from its parent gene, GAPDH, but does not encode a functional enzyme or receptor[1]. GAPDH itself is a highly conserved glycolytic enzyme with numerous cellular functions, but its pseudogenes, including GAPDHP74, are nonfunctional genomic copies found in multiple species[1]. The high number of GAPDH pseudogenes in the human genome reflects the retrotranspositional activity of the parent gene, but these pseudogenes, including GAPDHP74, do not have recognized coding or regulatory roles, nor are they considered therapeutic or diagnostic targets[1].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 74 (GAPDHP74).